euibis logo
EU-IBIS Home
Background
Participating countries
Neisseria meningitidis
Haemophilus influenzae
Reports

Links

Participants only area

External Links

Please note EU-IBIS bears no responsibility for the contents of the external sites listed below.

Meningitis and related diseases
 
Vaccines protecting against meningitis
 
Guidelines on the treatment of meningitis/meningoccocal disease
     -   English versions
     -   Other language versions
 
Websites of institutes pariticipating in the EU-IBIS project


Meningitis and related diseases

A number of bacterial and viral organisms cause meningitis, amongst them the bacterial species Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli, and enteroviruses, adenovirus and herpes simplex. EU-IBIS is concerned with two bacterial species, Neiseria meningitidis and Haemophilus influenzae.

Health Protection Agency
Meningitis Research Foundation
Meningitis Trust
NHS Direct
US National Center for Infectious Diseases
World Health Organisation   Haemophilus influenzae type b   Meningococcal meningitis
Neisseria.org   Neisseria meningtidis
US Centres for Diease Control and Prevention (technical information)   Haemophilus influenzae   Neisseria meningitidis
Sanger Institute (sequencing projects)   Haemophilus influenzae   Neisseria meningitidis
Wellcome Trust funded Multilocus Sequence Typing (MLST)   Haemophilus influenzae   Neisseria
Wikipedia   Haemophilus influenzae   Neisseria meningitidis


Vaccines protecting against meningitis

Both Haemophilus influenzae and Neisseria meningitidis occur in a variety of types, but only one type of the first (serotype b) and five of the second (serogroups A, B, C, W135, Y) cause significant diease in humans. A number of vaccines have been developed to protect against bacterial meningitis, each vaccine protecting only against a specific subset of bacterial strains, and none offering cross-species protection. The vaccines come in two forms: polysaccharide vaccines which consist of chains of sugar molecules derived from the surface of the corresponding organism, and conjugate vaccines, in which the same sugar molecules are chemically linked to a puriified protein, this generating a greater immunological and therefore protective response, particularly in younger children. The polysaccharide Neisseria meningitidis (meningococcal) polysaccharide vaccines are either bivalent (protecting against serogroups A and C) or tetravalent/quadrivalent (protecting against serogroups A, C, W135 and Y). The only meningococcal conjugate vaccine, MenC, protects against sergoroup C. The only Haemopnilus influenzae vaccine, Hib, is a conjugate vaccine protecting against serotype b.

World Health Organisation   Hib vaccine   Meningococcal vaccines
British National Formulary   Hib vaccine   Meningococcal vaccines
US Immunization Action Coalition   Hib vaccine   Meningococcal vaccines
Meningitis Vaccine Project (in sub-Saharan Africa)
Euromed 2003 (Keith Cartwright)   Meningococcal vaccines [pdf link]


Guidelines on the management of meningitis/meningococcal disease

Guidelines in English
General meningitis
  Infectious Diseases Society of America (2004)
  Médicins Sans Frontières (2005) [pdf link, 4.28MB, pp159ff]
Childhood meningitis
  World Health Organisation Integrated Management of Childhood Illnesses (2000)
  Melbourne Royal Children's Hospital (2005)
Adult meningiitis
  British Infection Society (2005)
General meningococcal disease
  Health Protection Agency/Communicable Disease and Public Health (2002)
  Australian Department of Health and Ageing (2004)
  Canadian Public Health Agency (2005)
Management of meningococcal epidemics
  World Health Organisation (1998)
  Médecins Sans Frontières (MSF) clinical guidelines (2004) [pdf link, 2.45MB]
Meningococcal disease in institutes of higher education
  Universities UK Student Experience Strategy Group (2004)
  US Advisory Committee on Immunization Practices (2000)
Use of antibiotics
  Effectiveness of antibiotics in preventing meningococcal disease (2004)
  Antibiotic guidelines and use in the Netherlands (2002)

Guidelines in French
General meningitis
  Médicins Sans Frontières (2005) [pdf link, 4.28MB, pp159ff]
General meningococcal disease
  Canadian Public Health Agency (2005)
Management of meningococcal epidemics
  World Health Organisation (1998)
  Médecins Sans Frontières (MSF) clinical guidelines (2004) [pdf link, 2.45MB]

Guidelines in other languages
Finland   Finnish version   Swedish version
Germany   German Standing Commission on Vaccination (STIKO)   Instructions for public health officials
Netherlands   Health guidance


Websites of institutes participating in the EU-IBIS project


Back to top
 

This page was last updated